Introduction {#section1-1533033818811150}
============

Radiotherapy treatment planning involves considerable interplanner and intraplanner variability, which leads to suboptimal plans, inconsistent planning results, and time inefficiencies.^[@bibr1-1533033818811150][@bibr2-1533033818811150]-[@bibr3-1533033818811150]^ Knowledge-based planning (KBP) and automated planning techniques are actively being developed to address these challenges and facilitate easier or faster means to attain optimal plans.^[@bibr4-1533033818811150][@bibr5-1533033818811150]-[@bibr6-1533033818811150]^

To facilitate automated planning, KBP trains predictive models on a knowledge base to predict the dose of new patients. This study compares the prediction accuracy of 3 learning and dose prediction methods for representative intensity-modulated radiation therapy (IMRT) sites and modalities. Statistical voxel dose learning (SVDL) bins each organ at risk (OAR) voxel according to their respective Euclidean distance to the planning target volume (PTV). Statistical voxel dose learning dose prediction has previously been reported to be fast and accurate.^[@bibr7-1533033818811150]^ However, it is difficult to incorporate additional geometrical features into SVDL, which could be considered a nonparametric machine learning method. In this study, additional geometrical features are included in the 2 parametric machine learning methods: spectral regression (SR) and support vector regression (SVR).

A key component in KBP is learning the correlation between patient anatomies and planning dose. To achieve this goal, Wu *et al* ^[@bibr8-1533033818811150]^ introduced the concept of the overlap volume histogram (OVH) and established its relationship with the dose--volume histogram (DVH). The OVH represents the relative spatial relationship between an OAR and the PTV. Points on the OVH are correlated with dose--volume points, which can perform predictions. This study evaluated the predicted dose-volume points for the PTV and OARs of 32 head and neck (HN) cases as quality control measures to aid in replanning. Support vector regression was used by Zhu *et al* ^[@bibr9-1533033818811150]^ and later by Yuan *et al*.^[@bibr2-1533033818811150]^ Principal component analysis (PCA) was performed on the spatial and volumetric input features to identify the relevant principal components (PCs). The PCs were used to train a SVR model using the DVH as output. The training set size for these studies ranged from 18 to 82 patients, demonstrating SVR's capability of mitigating overfitting with relatively small training sets. Appenzoller *et al* ^[@bibr10-1533033818811150]^ predicted the full DVH for prostate and HN cases by binning their distance to the target and performing a skew-normal fit on the voxel doses within each bin. The skew-normal fit was used to estimate the dose of new voxels according to their distance to the target, and the predicted DVH was calculated over the skew-normal fit of all OAR voxels. We have previously reported a comparison among OVH, skew-normal fitting, and SVDL prediction accuracy.^[@bibr7-1533033818811150]^ Statistical voxel dose learning is similar to the skew-normal fitting method, but instead of performing a skew-normal fit of voxel doses with the same geometrical feature, the median dose value of each distance bin was used, which resulted in comparable dose prediction and shorter computational time.

In addition to these relatively simple learning methods, artificial neural networks (ANNs) were used to predict brain stereotactic radiosurgery (SRS) and prostate dose distribution for voxels within 30 to 32 mm of the PTV.^[@bibr4-1533033818811150]^ Like SVR, ANNs are flexible in the number of input features, in this case using spatial and volumetric features as well as the number of fields and the voxel angle from the PTV centroid and principal coordinate system defined by PCA. Small training set sizes of 23 and 43 for prostate and SRS cases, respectively, were used for acceptable dose prediction accuracy (8%-10% average) for the small volume near the target. However, the computational time becomes intractable for larger regions of interest and more complex cases using the method.

A more sophisticated atlas-based dose prediction method was reported for HN patients.^[@bibr5-1533033818811150]^ Each patient in the training set represents 1 atlas, and computed tomography (CT) radiomics texture features were extracted to characterize each image. Feature extraction and characterization was then performed on CTs of the patients to implement atlas selection. This resulted in probabilistic dose estimates which were then used with a conditional random field to find the most likely voxel dose from similar atlases and evaluate the prediction accuracy. This method required relatively large training sets, with training set sizes ranging from 58 to 144 patients for the various treatment sites. It took 48 hours to train the model and additional 15 minutes for individual case prediction.

A summary of these dose prediction studies is presented in [Table 1](#table1-1533033818811150){ref-type="table"}. In clinical practice, KBP learning and prediction needs to balance the efficiency, sample size requirement, and accuracy. Although increasing the number of plans could increase the training accuracy theoretically, a large high-quality training set is not always attainable. The plan quality heterogeneity often increases with more plans included. Due to the need to repeatedly retrain the model with new or updated cases, the computational speed is also important. In this study, we focus on comparing learning methods that are fast, yet rely on relatively small data sets that are readily available at most clinics. A direct comparison of the dose prediction methods will provide guidance to automated treatment planning.

###### 

Summary of Previous Dose Prediction Studies.

![](10.1177_1533033818811150-table1)

                        Input Features                Predicted Output         Learning Method       Training Set Size   Disease Sites   Training Time   Prediction Time
  --------------------- ----------------------------- ------------------------ --------------------- ------------------- --------------- --------------- -----------------
  Wu *et al*            Overlap volume histogram      Dose--volume points      OVH-DVH correlation   32                  HN              \-              \-
  Zhu *et al*           Distance to target            DVH                      SVR                   18                  Prostate        \-              \-
  Yuan *et al*          Distance to target            DVH                      SVR w/PCA             64, 82              Prostate, HN    \-              \-
                        Structure volumes                                                                                                                
                        Overlap volumes                                                                                                                  
                        Out-of-field volume                                                                                                              
  Appenzoller *et al*   Distance to target            DVH                      Skew-normal fitting   20, 24              Prostate, HN    \-              \-
  Shiraishi *et al*     PTV volume                    Voxel dose               ANN                   23, 43              Prostate, SRS   4 hours         \-
                        Distance from structures      Within 30-32 mm of PTV                                                                             
                        Number of fields                                                                                                                 
                        Angles from PTV centroid                                                                                                         
                        Principal coordinate system                                                                                                      
  Tran *et al*          Distance to target            OAR voxel dose           SVDL                  20                  Liver           2-4 minutes     1 second
  McIntosh *et al*      Radiomics features            Image voxel dose         Atlas-based CRF       97                  Breast cavity   48 hours        15 minutes
                                                                                                     144                 Whole breast                    
                                                                                                     113                 CNS brain                       
                                                                                                     144                 Prostate                        
                                                                                                     77                  Lung                            
                                                                                                     58                  Rectum                          

Abbreviations: ANN, artificial neural network; CNS, central nervous system; CRF, conditional random field; DVH, dose--volume histogram; HN, head and neck; OAR, organ at risk; OVH, overlap volume histogram; PCA, principal component analysis; PTV, planning target volume; SVDL, statistical voxel dose learning; SVR, support vector regression.

Materials and Methods {#section2-1533033818811150}
=====================

Dose prediction for both noncoplanar IMRT (4π) and volumetric-modulated arc therapy (VMAT) was performed for HN, lung, and prostate cases. It is the current standard-of-care modality in IMRT. The 4π radiotherapy was developed to substantially improve dose conformity and normal tissue sparing by optimizing noncoplanar beam angle selection. This improved dosimetry has been reported for liver,^[@bibr11-1533033818811150],[@bibr12-1533033818811150]^ lung,^[@bibr13-1533033818811150]^ brain,^[@bibr14-1533033818811150]^ prostate,^[@bibr15-1533033818811150],[@bibr16-1533033818811150]^ and HN^[@bibr17-1533033818811150]^ cases. Both modalities can be automated using a voxel-based optimization without a need to manually select the beams, making them well suited for KBP automated treatment planning.

The patient cohorts and their respective planning techniques for this study were chosen as listed in [Table 2](#table2-1533033818811150){ref-type="table"}. Twenty patients were selected for each treatment site. Predictions were performed using k-fold cross-validation with k = 4, resulting in training set sizes of 15 patients. These 3 disease sites were chosen as we believe them to be generally representative of IMRT planning cases. Patients' CTs and VMAT plans were retrospectively obtained from the clinic under an institutional review board--approved protocol (IRB\# 12-001882). Head and neck and lung cases were replanned using 4π optimization in MATLAB (version 2017a; Mathworks, Natick, Massachusetts).^[@bibr11-1533033818811150]^

###### 

Patient Cohort Disease Sites and Planning Techniques.

![](10.1177_1533033818811150-table2)

         Head and Neck   Lung   Prostate
  ------ --------------- ------ ----------
  4π     X               X      
  VMAT   X                      X

Abbreviation: VMAT, volumetric-modulated arc therapy.

Although noncoplanar beams have been shown to improve the dosimetry,^[@bibr11-1533033818811150],[@bibr15-1533033818811150],[@bibr16-1533033818811150],[@bibr13-1533033818811150]^ the delivery of such beams can be challenging due to potential patient collision. Furthermore, prostate dose constraints are typically met with coplanar arc beams. For these reasons, we only included coplanar VMAT plans for prostate cases. On the other hand, dose compactness has a much higher importance in lung stereotactic body radiation therapy (SBRT) with dose prescriptions of 12.5 Gy in 4 fractions.^[@bibr18-1533033818811150],[@bibr19-1533033818811150]^ Noncoplanar 4π treatment is particularly effective in reducing the high dose spillage and improving dose conformality.^[@bibr13-1533033818811150]^ The current study focuses on centrally located lung tumors. Lastly, HN cases represent the most challenging disease site, commonly including up to 40 OARs with complex PTV shapes, location, and various prescription dose levels. Head and neck cases are highly diverse based on the origin of the tumors and the laterality. In this study, without losing generality, we focused on oropharyngeal tumors, which are representative of the complex HN anatomy. Both 4π and VMAT plans were included for HN cases as they could both be valuable depending on actual dosimetric requirement and delivery time.

For each site, there are numerous OARs to predict. All relevant OARs with clinical dose constraints were predicted. We tested predictions from models trained independently on each OAR as well as those trained on all OAR voxels collectively. Separate models allow more specialized predictions, but combining all voxels ensures large training data. For the VMAT predictions, voxels were separated to in-beam and out-of-beam groups based on their axial slice location relative to the PTV voxels.

Dose Prediction Techniques {#section3-1533033818811150}
--------------------------

We used the median-approximated SVDL method as described by Tran *et al*.^[@bibr7-1533033818811150]^ Computed tomography and dose arrays were resampled into isotropic 0.25 × 0.25 × 0.25 cm^3^ voxels. The only voxel information used in this SVDL is the Euclidean distance to the PTV surface. Voxels are sorted into bins based on their distance to the PTV and the median dose of each distance bin calculated. The median dose is then used as the predicted dose of each new voxel of the same distance to the PTV. Statistical voxel dose learning can be viewed as a weighted nearest neighbor regression using the median statistic. As such, SVDL is robust to noise on both the input feature vector and mapped dose value.

Spectral regression and SVR are supervised machine learning models that can predict an output value from input features. In this case, the features included the distance to the PTV ($r = \sqrt{x^{2} + y^{2} + z^{2}}$), *r* ^2^, *r* ^3^, $r^{- 1}$,$,r^{- 2}$, *y*, *z*, *x* ^2^, *y* ^2^, $z^{2},\, x^{- 1},\, y^{- 1},\, z^{- 1}$, $xy$, $yz$, $xz$, $\sqrt{x^{2} + y^{2}}$, $\sqrt{y^{2} + z^{2}}$, $\sqrt{x^{2} + z^{2}}$, angle from PTV centroid, angle from linac source, PTV volume, $\text{PTV\ volume}.^{2}$, $\text{OAR\ volume}$, $\text{OAR\ volume}^{2}$, $\frac{\text{OAR\ volume}}{\text{PTV\ volume}}$, and $\frac{\text{PTV\ volume}}{\text{OAR\ volume}}$, resulting in a total of 28 features. Spectral regression and SVR predictions were performed using the aforementioned features as well as using PCA. Principal component analysis transforms the feature vectors into orthogonal PCs that are linearly uncorrelated and variance preserving. Principal component analysis allows control of the degree of dimension reduction by simply choosing how many PCs to train on. Dose predictions with PCA were performed with 1 to 28 PCs to find the ideal number of PCs for each case and compared with predictions using the original features. Pearson correlation coefficients (*R*) were evaluated between all pairs of PCs and original features.

Spectral regression is a modified form of ridge regression realized through a subspace learning formulation.^[@bibr20-1533033818811150]^ The SR algorithm discovers the subspace embedding vectors as the eigenvectors of an eigenproblem involving the similarity matrix from spectral graph theory,^[@bibr21-1533033818811150]^ with flexible regularization options such as L2 (ridge) regularization. The SR for radiotherapy dose prediction has not been studied before, and it was performed using the open source MATLAB code from Cai *et al*.^[@bibr20-1533033818811150],[@bibr22-1533033818811150],[@bibr23-1533033818811150]^ The prediction model is based on subspace learning using the input features and corresponding voxel dose labels of the training set. This prediction model produces an embedding vector of the same length as the feature vectors; hence, prediction for new voxels is a simple dot product.

Support vector regression is based on support vector machines, which is a large margin classifier. Support vector machines are used for the classification of new data into separate categories. It trains a model by defining a decision boundary that maximizes the margin separating different categories in labeled training data. Support vector machines use kernel-induced features to specify nonlinear decision boundaries, allowing considerable flexibility in prediction models. Instead of defining decision boundaries to separate categories, SVR trains a regression function that minimizes the error of data points outside of the margin. Support vector regression in combination with PCA has previously been demonstrated to predict specific dose--volume points.^[@bibr2-1533033818811150]^ It was performed using LIBSVM, an open source software library for support vector optimization.^[@bibr24-1533033818811150]^ The ν-SVR model was chosen after preliminary comparison with ε-SVR due to more consistent and accurate predictions. Large OARs were downsampled to a maximum of 20 000 voxels due to the substantial time requirements for SVR.

Both SR and SVR require tuning of hyperparameters to ensure the models are properly trained for our specific task. Spectral regression uses the Tikhonov regularization parameter, α, and SVR requires selection of a kernel and tuning of the penalty parameter, C, and kernel parameters. Linear, polynomial, radial basis function, and sigmoid kernels were evaluated for the SVR regressions. Parameters were tuned with exhaustive grid searches in exponential increments (eg, α = 0.1, 0.3, 1, 3, 10,...).

After the optimal parameters for SR and SVR were found, overfitting analysis was performed by predicting one of the 5 patient test cohorts with training set sizes varying from 1 to 15 patients. If the prediction error does not converge, it would indicate that larger training sizes would improve the accuracy and that overfitting is likely a problem with our training set size.

Prediction Accuracy Analysis {#section4-1533033818811150}
----------------------------

All dose prediction methods in this study are capable of predicting the 3D voxel dose for each OAR. Both root mean squared error (RMSE) and mean absolute error (MAE) were used to evaluate the voxel dose prediction accuracy,
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where n is the number of voxels and ${\hat{d}}_{i}$ and *d~i~* are the predicted and actual doses, respectively. Both prediction accuracy measures keep the original units (Gy) that can be intuitive to interpret. The errors were calculated for each predicted OAR as well as for all OAR voxels as a whole.

The DVH prediction accuracy was also evaluated, as it still contains relevant clinical information. The mean absolute difference (MAD) of the actual and predicted DVHs was calculated for each prediction,
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where *m* is the number of DVH bins, separated by 0.05 Gy. Since the DVH is conveyed as a fractional volume, MAD is reported in units of percentage. Mean absolute difference is compared between the DVH predictions of SVDL and the SR and SVR models with the lowest voxel dose error.

Results {#section5-1533033818811150}
=======

Exhaustive grid search resulted in different optimal SR and SVR hyperparameters depending on the accuracy measure, RMSE or MAE. To illustrate the problem, the lung 4π RMSE and MAE results are shown in [Table 3](#table3-1533033818811150){ref-type="table"}. The optimal hyperparameters would ideally match, whether we optimized the regression parameters based on RMSE or MAE. However, since they resulted in differing parameters, we visually compared the results to determine whether they are representative of a realistic dose prediction. Isodose color wash comparisons are shown in [Figure 1](#fig1-1533033818811150){ref-type="fig"}. Root mean squared error-optimized dose predictions better approximate the sharp dose gradient of the PTV surface; hence, RMSE was used for the remainder of the study for evaluations of prediction accuracy. In fact, the prediction optimized for MAE resulted in piecewise constant dose predictions, where most of the voxel doses were equal to zero.

###### 

Root Mean Squared Error and Mean Absolute Error Results for RMSE-Optimized and MAE-Optimized Lung 4π Spectral Regression and Support Vector Regression Dose Predictions.

![](10.1177_1533033818811150-table3)

  \(a\)            Alpha   RMSE       MAE      
  ---------------- ------- ---------- -------- -------
  RMSE-optimized   10^2^   5.497599   3.682    
  MAE-optimized    10^9^   5.812917   1.78     
  \(b\)            C       Gamma      RMSE     MAE
  RMSE-optimized   1       0.5        4.0196   1.706
  MAE-optimized    0.01    0.5        4.957    1.568

Abbreviations: RMSE, root mean squared error; MAE, mean absolute error.

![Representative isodose color wash comparison between root mean squared error (RMSE)- and mean absolute error (MAE)-optimized spectral regression and support vector regression dose predictions for an example lung 4π case. The planning target volumes (PTVs) are shown in white.](10.1177_1533033818811150-fig1){#fig1-1533033818811150}

A representative example of the overfitting analysis is shown in [Figure 2](#fig2-1533033818811150){ref-type="fig"}. All other treatment sites exhibited the same trend. Both SR and SVR prediction accuracy did not converge using the training set sizes we had available. The RMSE was still decreasing using our largest training set of 15 patients.

![Dose prediction root mean squared error (RMSE) using spectral regression and support vector regression with varying training set size.](10.1177_1533033818811150-fig2){#fig2-1533033818811150}

The voxel dose prediction RMSEs are shown in [Figure 3](#fig3-1533033818811150){ref-type="fig"}. Between the parametric machine learning methods, SVR consistently achieved lower prediction errors compared to SR, both with and without PCA. Nevertheless, both parametric machine learning methods are inferior to SVDL in RMSE. The SVDL prediction RMSE for HN is greater (3.91 Gy 4π and 3.21 Gy VMAT) than for the prostate (2.35 Gy) and the lung (2.49 Gy). The actual and predicted OAR voxel dose of an example case is illustrated in [Figure 4](#fig4-1533033818811150){ref-type="fig"} as isodose color washes.

![Root mean squared error of dose predictions for (A) head and neck 4π, (B) head and neck volumetric-modulated arc therapy (VMAT), (C) lung 4π, and (D) prostate VMAT. All results shown are for predictions using separate models for each organ at risk (OAR). Errors for spectral regression (SR) and support vector regression (SVR) using principal component analysis are shown with varying numbers of principal components (PCs). Root mean squared error for statistical voxel dose learning (SVDL), which only uses the voxel distance to the planning target volume (PTV), and SR and SVR using the original geometrical features are shown as dashed lines.](10.1177_1533033818811150-fig3){#fig3-1533033818811150}

![Isodose images of the actual and predicted organ at risk (OAR) voxel dose for representative example head and neck (HN), lung, and prostate cases. The planning target volumes (PTVs) are shown in white.](10.1177_1533033818811150-fig4){#fig4-1533033818811150}

Combining all OAR voxels into the same prediction model to enlarge the training set size did not offset the advantage of specialized models for each OAR. For all cases, collectively training on all OAR voxels resulted in increased prediction error of 11.7% (SVDL), 6.7% (SR), and 19.0% (SVR).

Principal component analysis reduced the SR and SVR error for all 4π cases, except for lung 4π with SR, in which case using PCA yielded worse accuracy than SR without PCA (−4.74%). Dimension reduction with PCA had no effect in improving VMAT dose prediction. For HN VMAT prediction, using PCA with SR also resulted in worse performance than SR using the original features (−4.20%). With the inclusion of more PCs in 4π prediction, RMSE outcome was noisy but typically reduced the error. As shown in [Figure 3](#fig3-1533033818811150){ref-type="fig"}, SVR and SR for HN 4π and SVR for lung 4π had general prediction improvement with more PCs. In the case of lung 4π, the inclusion of more PCs exhibited a valley trend, seen with 10 to 27 PCs in [Figure 3C](#fig3-1533033818811150){ref-type="fig"} as the solid blue line. In the analysis of correlations between the PCs and original features, Pearson correlation coefficients (*R*) greater than 0.7 were observed between PC1 and *r* ^2^ (*R* = 0.96), PC4 and the $\text{PTV}\,\text{volume}$ (*R* = 0.78), and PC7 and $\frac{\text{PTV\ volume}}{\text{OAR\ volume}}$ (*R* = 0.90). All other PCs had no strong correlation with the original features. From observation of the resulting coefficients, 0.7 was chosen as the cutoff for strong correlation as most other PC-feature combinations had coefficients less than 0.4.

[Figure 5](#fig5-1533033818811150){ref-type="fig"} shows the RMSE for dose prediction of each OAR for the most accurate method (SVDL in all cases). The box plots illustrate the range of error for each of the 20 patients' OAR prediction. For HN 4π predictions, there are consistently large errors for the cricoid pharyngeal inlet (CPI) and temporomandibular joints (TMJs). These errors are also present in HN VMAT predictions, but not to the same scale. The HN VMAT predictions have more intermediately sized errors for other OARs, namely the parotids, mandible, lips, cochlea, larynx, pharynx, esophagus, oral cavity, and submandibular glands. Lung 4π predictions were mostly consistent through each OAR. All OARs had a few outliers except for the lung, esophagus, and liver. The prostate VMAT predictions are overall scaled lower than the other sites and even the outliers have considerably lower error.

![Root mean squared error of statistical voxel dose learning (SVDL) dose predictions for each organ at risk (OAR).](10.1177_1533033818811150-fig5){#fig5-1533033818811150}

The prediction error for DVHs was also evaluated using MAD between the actual DVH and the 3 predicted DVHs. Box plots of the MAD results for the 20 patients of each treatment site are shown in [Figure 6](#fig6-1533033818811150){ref-type="fig"}. A representative DVH with the predicted DVHs is shown in [Figure 7](#fig7-1533033818811150){ref-type="fig"}. Mean absolute difference in the DVH fractional volumes across the tabulated dose bins is reported in units of percentage. However, it is important to note that MAD is not a percent difference metric. Overall, SVDL produced an average MAD of 4.33, compared to 7.37 and 5.65 for SR and SVR, respectively. For reference, the atlas-based dose prediction method introduced by McIntosh and Purdie^[@bibr5-1533033818811150]^ resulted in an average MAD of 1.33 and 2.12 for lung and prostate, respectively. However, it is important to note the differences both in training set size and computational time with their method, which used 77 lung and 144 prostate plans and took 48 hours for training.

![Mean absolute difference in fractional volume for the dose-volume histogram (DVH) predictions of 20 patients of each site for (in order from left to right) statistical voxel dose learning (SVDL), spectral regression (SR), and support vector regression (SVR).](10.1177_1533033818811150-fig6){#fig6-1533033818811150}

![Comparison of the predicted and actual dose for representative example dose--volume histogram (DVHs). The structures shown in each of these examples are the pharynx (head and neck), heart (lung), and femoral head (prostate).](10.1177_1533033818811150-fig7){#fig7-1533033818811150}

All prediction methods are relatively fast compared to the typical planning time for voxel-based 4π and VMAT optimization. Average training times were 24.0 seconds (SVDL), 0.06 seconds (SR), and 87.7 seconds (SVR) for each OAR training set. Average prediction times were 0.03 seconds (SVDL), 0.01 seconds (SR), and 0.89 seconds (SVR) for each new patient OAR.

Discussion {#section6-1533033818811150}
==========

Counterintuitively, despite more geometrical features being included, the parametric machine learning methods were less accurate than the simple SVDL for both voxel dose and DVH predictions. Feature reduction using PCA was not able to substantially improve the results. Using some or all of the PCs from PCA improved the SR or SVR prediction accuracy over using the original features, but only for 3 of the four 4π predictions. This is likely because the VMAT predictions already separated in-beam and out-of-beam voxels, making the Euclidean distance to the PTV the primary relevant feature for VMAT cases. Conversely, 4π dose distributions are much more dependent on the relative 3D spatial differences than just the axial in-beam and out-of-beam categories. By organizing the features into high variance, orthogonal PCs, the parametric machine learning methods can better utilize the data to improve the prediction accuracy. Strong correlations were found between PCs and *r* ^2^, $\text{PTV}\,\text{volume}$, and $\frac{\text{PTV\ size}}{\text{OAR\ size}}$. This indicates that these particular features are mostly orthogonal with each other and an increase in model complexity could be beneficial. In general, the increase in error with reduction in PCs suggests that dimension reduction unnecessarily excludes uncorrelated information. The valley trend for PCs in lung 4π SR suggests that for this particular case, the full set of features is unnecessary to predict the dose.

Additionally, prediction accuracy was not improved by training a model using all OAR voxels, which resulted in even higher error. A possible reason is that SR and SVR are more dependent on their respective training sets, with variable dose gradients for the different OAR predictions. A training set size analysis was performed to understand the performance of SR and SVR. The results indicate that overfitting exists for the current training set size. Larger training sets are likely required to fully take advantage of the machine learning methods. However, when the training set is practically limited, the study demonstrates that SVDL can better predict the 3D dose distribution and DVH. Statistical voxel dose learning collapses the available data into one estimated number for each distance bin. This makes it more naive to the variations of PTV and OAR geometry, resulting in site-dependent prediction error. This is evident in the isodose images in [Figure 4](#fig4-1533033818811150){ref-type="fig"}. Realistic voxel dose predictions require sharp dose falloffs near the PTV boundary but otherwise smooth transitions. Statistical voxel dose learning consistently maintains this sharp dose gradient by independently estimating each distance bin. In contrast, the SR and SVR methods are unable to achieve these gradient qualities, instead having abrupt dose gradients between OARs and at the primary beam plane. Statistical voxel dose learning is able to consistently produce such dose distributions because the same predicted dose is applied to all voxels of the same distance to the PTV.

An interesting observation for the machine learning methods is the apparent discrepancy in the RMSE and MAE trends for the same regularization parameter tuning. The discrepancy between MAE- and RMSE-optimized dose predictions is due to their different preferences to small and large errors. Mean absolute error allows larger outliers as long as most voxel residuals are minimal. However, RMSE penalizes large residuals more than small errors. In the case where the MAE is minimized by heavily regularizing the predicted dose distribution, a nearly piecewise constant dose distribution resulted that is drastically different from realistic dose distributions because MAE is dominated by the majority of voxels with near zero dose and forgiving toward the few voxels with substantial dose. Therefore, the RMSE metric is better correlated with realistic dose distributions and was chosen as the sole accuracy measure for the rest of the study.

Although only a subset of HN cases were included, that is, oropharyngeal, these cases are still highly variable in relative organ geometry, dose prescription levels, and PTV. This high variance contributed to the overall higher HN prediction error compared to lung and prostate cases. Although the lung tumor locations vary, fewer and larger OARs are involved, resulting in more consistent prediction than HN. Prostate dose prediction RMSE had the least amount of variability as would be expected due to the more consistent geometry in prostate cases.

The comparison of the OAR prediction accuracy between HN 4π and VMAT highlights interesting differences between the 2 modalities. The VMAT prediction inherently accounts for beam orientation, as in-beam and out-of-beam voxels are separate. However, since 4π performs simultaneous beam angle selection with fluence map optimization, it is impossible to preemptively sort in-beam and out-of-beam voxels for 4π. Despite this difference, 4π prediction had relatively low errors for most OARs, except for the CPI and TMJs, which are small organs near the PTV and can be particularly affected by primary beam paths. In contrast, for HN VMAT prediction, organs at the same level of the PTV had higher RMSEs than OARs out of the VMAT arc plane. This is most likely because they are close to the PTV and in the high-dose gradient region. These organs are very small (\<3 cm^3^) and are often near the PTV, leading to a greater degree of dosimetric variability and thus inferior dose prediction accuracy.

Conclusion {#section7-1533033818811150}
==========

This study compared 3 learning methods using limited training set sizes for the dose prediction of 4π noncoplanar IMRT and coplanar VMAT plans for HN, lung, and prostate patients. Statistical voxel dose learning not only was found to be a simpler approach compared to SR and SVR but also produced the lowest prediction error for all cases. Principal component analysis was useful in improving SR and SVR dose prediction accuracy for 4π prediction in most cases, but still could not reach the accuracy of SVDL. Training set size analysis found that the parametric machine learning predictions could be improved with larger training sets due to overfitting. Among the 3 sites, prostate plans had the lowest prediction error, with HN producing the highest error. Using separate OAR-specific prediction models was more beneficial than trying to increase data set size by including all OAR voxels in the training set. All training methods utilize clinically feasible time, but SVR is considerably slower than the other 2 methods.
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:   artificial neural network

CPI

:   cricoid pharyngeal inlet

CT

:   computed tomography

DVH

:   dose--volume histogram
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:   head and neck

IMRT

:   intensity-modulated radiation therapy

KBP

:   knowledge-based planning

MAD

:   mean absolute difference

MAE

:   mean absolute error

OAR

:   organ at risk

OVH

:   overlap volume histogram

PC

:   principal component

PCA

:   principal component analysis

PTV

:   planning target volume

RMSE

:   root mean squared error

SR

:   spectral regression

SVDL

:   statistical voxel dose learning

SVR

:   support vector regression

TMJ

:   temporomandibular joints

VMAT

:   volumetric-modulated arc therapy.
